Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
 
Skip navigation

Our research into drug resistance

Cancer is a complex disease both to understand and to treat. One of the greatest challenges facing scientists and doctors is the problem of ‘drug resistance’.

This is where a person's cancer does not respond to a treatment that works well for others with the same disease. In some cases, people develop resistance during the course of their treatment - the drugs that they were initially prescribed stop working.

Cancer Research UK-funded scientists are leading the world in understanding drug resistance and identifying ways to overcome this hurdle. Importantly, this information could also allow doctors in the future to predict who will and who won’t respond well to particular drugs.

Below are some of the highlights of our drug resistance research portfolio

Researcher listing

8 researchers found. Filter results:

CRI researcher Jason Carroll profile image
Jason Carroll

Hormones, drugs and breast cancer

Cancer Research UK Cambridge Institute

Researcher Caroline Dive profile image
Caroline Dive

Developing new cancer treatments
Clinical & Experimental Pharmacology Group

Paterson Institute for Cancer Research

Researcher Paddy Johnston profile image
Patrick Johnston

Centre for Cancer Research and Cell Biology

Queen's University Belfast

Default user avatar
Simon Mackay

University of Strathclyde

Researcher Ultan McDermott profile image
Ultan McDermott

Cancer Genome Project

Wellcome Trust Sanger Institute

CRI researcher David Neal profile image
David Neal

Better screening and treatment for prostate cancer
Department of Oncology

Cancer Research UK Cambridge Institute

LRI researcher Charles Swanton profile image
Charles Swanton

Translational Cancer Therapeutics Laboratory

London Research Institute

Default user avatar
David Waugh

Improving radiotherapy for prostate cancer

Queen's University Belfast